CN104849470A - Enterohemorrhagic E.coli O157:H7 latex agglutination detection kit and application thereof - Google Patents

Enterohemorrhagic E.coli O157:H7 latex agglutination detection kit and application thereof Download PDF

Info

Publication number
CN104849470A
CN104849470A CN201510189310.7A CN201510189310A CN104849470A CN 104849470 A CN104849470 A CN 104849470A CN 201510189310 A CN201510189310 A CN 201510189310A CN 104849470 A CN104849470 A CN 104849470A
Authority
CN
China
Prior art keywords
latex
control sample
reagent
kit
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510189310.7A
Other languages
Chinese (zh)
Other versions
CN104849470B (en
Inventor
罗玲
艾地云
罗青平
邵华斌
张腾飞
王红琳
汪宏才
温国元
张蓉蓉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Zhengdakang Biotechnology Co ltd
Original Assignee
Institute of Animal Science and Veterinary of Hubei Academy of Agricultural Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Animal Science and Veterinary of Hubei Academy of Agricultural Sciences filed Critical Institute of Animal Science and Veterinary of Hubei Academy of Agricultural Sciences
Priority to CN201510189310.7A priority Critical patent/CN104849470B/en
Publication of CN104849470A publication Critical patent/CN104849470A/en
Application granted granted Critical
Publication of CN104849470B publication Critical patent/CN104849470B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to an enterohemorrhagic E.coli O157:H7 latex agglutination detection kit and an application of the detection kit in detection of enterohemorrhagic E.coli O157:H7. The kit comprises: a) a latex detection reagent; b) a sample treating fluid; c) a positive control sample; and d) a negative control sample. The latex detection reagent is a latex reagent which can be subjected to a specific reaction with enterohemorrhagic E.coli O157:H7, and is obtained from Intimin monoclonal antibody sensitized carboxylated polystyrene latex. The kit provided by the invention has the following advantages: 1, the kit is simple to operate, is convenient and fast, has low detection cost and is suitable for rapid on-site detection; 2, coupling rate of antibody and sensitivity and stability of the latex detection reagent are improved, and requirements of product research and mass production are met; and 3, the kit can be used to directly detect enterohemorrhagic E.coli O157:H7 in a sample and has characteristics of strong specificity, high sensitivity and short detection time.

Description

A kind of enterorrhagia Bacillus coil 0157: H7 latex agglutination assay kit and application
Technical field
The present invention relates to a kind of enterorrhagia Bacillus coil 0157: H7 latex agglutination assay kit and at enterorrhagia Bacillus coil 0157: the application during H7 detects, belong to bird immunity and to learn a skill field.
Background technology
Enterorrhagia Bacillus coil 0157: H7 is a kind of important foodborne bacterial pathogens, is one of main inducing of food security and the Sudden sensorineural hearing loss that the world today is on the increase.This bacterium energy infected poultry and other animal, the food morbidity of people mainly through polluting.Nineteen eighty-two, first O157:H7 finds in the U.S., after this distributes all over the world or local popular, has become global public health and food-safety problem.Therefore development fast, responsive, special detection method and reagent guarantees to drink water and food security, prevention Escherichia coli O 157: H7 infect the important means occurred.At present, the detection method reported both at home and abroad has multiplex PCR, genetic chip, bacteriophage typing, pulsed-field gel electrophoresis analysis, biology sensor etc., these methods have his own strong points in context of detection, but large multipair instrument and equipment requires higher, and therefore usable range has significant limitation.Be separated culture identification and be still the goldstandard detecting O157:H7, but it needs a couple of days just can obtain result usually, can not meet the requirement of quick diagnosis.At Escherichia coli O 157: in the immunological detection method of H7, antibody used mostly is polyclonal antibody, the polyclonal antibody of anti-O157:H7 also exists serious cross reaction with the antibody of other enteric bacteria anti-, common purifying can not meet accurate serologic test demand, and with the antigen detection method set up based on monoclonal antibody and the domestic and international rare report of reagent.Latex agglutination test take polystyrene latex particulate as carrier, is adsorbed onto on carrier by antigen or antibody, in order to detect the method for corresponding antibody or antigen.The method is easy and simple to handle, convenient and swift, cheap, does not need specific apparatus, and naked eyes can judged result, is applicable to field quick detection, is widely used in clinical detection.Mode mainly physisorphtion and the chemical crosslink technique of conventional sensitization latex, physisorphtion stability and susceptibility lower, be difficult to the needs of applicable product development.
Summary of the invention
The object of the invention is to the defect overcoming prior art, set up one and detect enterorrhagia Bacillus coil 0157 fast: H7 latex agglutination assay kit, this kit selects anti-enterorrhagia Bacillus coil 0157: H7Intimin protein monoclonal antibody sensitization carboxylated polystyrene latex reagent, and it is a kind of for detecting enterorrhagia Bacillus coil 0157 for core assembles to detect reagent with this latex: the kit of H7, this kit can detect enterorrhagia Bacillus coil 0157 fast: H7, to the epidemiology survey of this disease and prevention and control significant.
The present invention solves the problems of the technologies described above the technical scheme taked to be: a kind of enterorrhagia Bacillus coil 0157: H7 latex agglutination assay kit, it is characterized in that this kit comprises: a) latex detects reagent, b) sample treatment liquid, c) positive control sample, d) negative control sample, it is energy and enterorrhagia Bacillus coil 0157 that described latex detects reagent: the latex reagent of H7 specific reaction, adopts anti-Intimin protein monoclonal antibody sensitization carboxylated polystyrene latex gained.
By such scheme, the preparation method of described anti-Intimin protein monoclonal antibody is: screen from 5 strain of hybridoma building strain 1 strain antibody tire height, high specificity hybridoma expand and cultivate, simultaneously in BALB/c mouse body, induce mouse ascites manufacture order clonal antibody; Get the BALB/c mouse 20 in 8 week age, only, the injection of 7d pneumoretroperitoneum expands the hybridoma 5 × 10 cultivated to the incomplete freund adjuvant 0.5mL/ of lumbar injection 6~ 5 × 10 7/ only, breeding observing, until mouse web portion projection and by only extracting mouse ascites when being slow in action, the centrifugal 8min of 2000r/min, discard fat and collect upper strata clarification ascites, measure with indirect ELISA method every the mouse ascites collected and tire, will tire and be not less than 1:(1000 × 2 11) ascites mixing, mixed ascites is finally tired after measured as 1:(1000 × 2 12), hypotype is accredited as lgG2b.
The concrete preparation method of described anti-Intimin protein monoclonal antibody sensitization carboxylated polystyrene latex: (1) is got the carboxylated polystyrene latex 200ul shaken up and put into EP pipe; (2) wash 3 times, 12000rpm, 15min with pH9.6,0.1M carbonate buffer solution, centrifugally abandon supernatant; (3) use pH4.5 again, the phosphate buffer of 0.01M washes 3 times, 12000rpm, 15min, centrifugal, abandons supernatant; (4) the NHS 1000uL then adding EDC 1000uL, 20mM of 100mM is resuspended, mixing, and make both final concentrations be respectively 50mol/L and 10mol/L, in shaking table, 26 DEG C slowly jolt 4.5h; (5) wash 3 times, 12000rpin, 20min with pH8.0,0.01M borate buffer solution, centrifugally abandon supernatant; (6) suspend with pH8.0,0.01M borate buffer solution 1000ul, suspension latex concentration is 2%, 4 DEG C and saves backup; (7) the anti-enterorrhagia Bacillus coil 0157 that 1:4 doubly dilutes dropwise slowly is added: H7Intimin protein monoclonal antibody 1000ul, the protein content 2.78mg/mL of described protein monoclonal antibody, it is 1 hour that loading time controls, in 26 DEG C of shaking tables, slowly jolt 5h; (8) add 0.1M monoethanolamine 100ul, in 26 DEG C of shaking tables, slowly jolt 15min cessation reaction, 12000rpm, 20min, centrifugally abandon supernatant; (9) precipitation pH8.0,0.01M borate buffer solution washes 3 times, 12000rpin, 20min, centrifugally abandons supernatant; (10) precipitation pH8.0,0.01M borate buffer solution 2000ul suspends, and is the good latex of sensitization and detects reagent, 4 DEG C of preservations.
By such scheme, the component of described sample treatment liquid and content by weight/volume is: take tryptone 20.0g, No. 3 cholate 1.12g, lactose 5.0g, ADKP 4.0g, anhydrous potassium dihydrogenphosphate 1.5g, NaCl 5.0g, is dissolved in 1000ml ddH by mentioned component 2o, adjust pH is 6.9 ± 1,121 DEG C of autoclaving 15min, and the ovobiocin solution 20mg/L taking out filtration sterilization adds, and makes ultimate density be 20ug/L.
By such scheme, described positive control sample is the enterorrhagia Bacillus coil 0157 of deactivation: H7 bacteria suspension, and described negative control sample is not containing the autoclaved TSB nutrient solution of Escherichia coli O 157: H7.
The present invention selects chemical crosslink technique, the carboxylated polystyrene latex with carboxylic group (-COOH) is utilized to be carrier, with bifunctional reagent water-soluble carbodiimide (EDAC) for medium, by chemical reaction, antibody molecule is coupled to latex surface, its stability and susceptibility improve a lot.Intimin albumen (namely closely plain) is Escherichia coli O 157: the outer membrane protein of the eae gene code on H7LEE pathogenicity island; its mediating bacterial and epithelial close adhesion; it is most important adhesion factor; specific antibody sticking of bacterium capable of blocking of tight element and make it lose pathogenicity, there is stronger immunogenicity and immune protective.For this reason, select anti-enterorrhagia Bacillus coil 0157: H7Intimin protein monoclonal antibody sensitization carboxylated polystyrene latex detects reagent as latex of the present invention, and simple and convenient assembly is kit fast.
Enterorrhagia Bacillus coil 0157 of the present invention: the application of H7 latex agglutination assay kit, is characterized in that comprising following concrete steps: the measuring samples 37 DEG C of cultivation 4-6 hour in sample treatment liquid 1) will collected; 2) on clean slide or glass plate, 10ul positive control sample, 10ul negative control sample and 10ul measuring samples is dripped respectively, and then heliotropism control sample, negative control sample, the latex dripped in measuring samples described in 10ul detect reagent, abundant mixing, slow shake, after 1 minute under blue background observations; 3) result judges: control test occurs following result in 1 minute, and test can be set up: positive control sample and latex detect reagent effect and occur +++ above latex agglutination, and negative control sample and latex detect reagent effect not aggegation; Measuring samples occurred in 1 minute ++ above latex agglutination is judged to the positive, presents original even emulsus and is judged to be feminine gender.
Detection kit of the present invention can directly to the enterorrhagia Bacillus coil 0157 in sample: H7 detects, if containing enterohemorrhagic enterorrhagia Bacillus coil 0157: H7 in sample, then latex detection reagent occurred in 1 minute ++ above latex agglutination, can be judged to positive findings; If not containing enterorrhagia Bacillus coil 0157: H7 in sample, then latex detection reagent drop in 1 minute still presents original even emulsus, can be judged to negative findings.
The present invention compared with prior art, has the following advantages:
1, detection kit of the present invention is without the need to specialized operations technical ability and any special instruments and equipment, simple, convenient quick, testing cost is low, is applicable to on-the-spot quick detection;
The shortcomings such as when 2, detection kit of the present invention overcomes latex sensitizing antibody, Conjugate ratio is low, antibody easily comes off, improve susceptibility and stability that the Conjugate ratio of antibody and latex detect reagent, are applicable to the requirement of research and development of products and large-scale production;
3, detection kit of the present invention can directly to enterorrhagia Bacillus coil 0157 in sample: H7 detects, and has high specificity, the feature that highly sensitive, detection time is short.
Accompanying drawing explanation
Fig. 1 is latex agglutination result process decision chart.
Embodiment
Below in conjunction with specific embodiment, illustrate the present invention further.Should be appreciated that these examples are only not used in restriction the scope of protection of present invention for illustration of the present invention.
The anti-enterorrhagia Bacillus coil 0157 of embodiment 1: the preparation of H7intimin protein monoclonal antibody sensitization latex reagent
The preparation method of anti-Intimin protein monoclonal antibody is: screen from 5 strain of hybridoma building strain 1 strain antibody tire height, high specificity hybridoma expand and cultivate, simultaneously in BALB/c mouse body, induce mouse ascites manufacture order clonal antibody; Get the BALB/c mouse 20 in 8 week age, only, the injection of 7d pneumoretroperitoneum expands the hybridoma 5 × 10 cultivated to the incomplete freund adjuvant 0.5mL/ of lumbar injection 6~ 5 × 10 7/ only, breeding observing, until mouse web portion projection and by only extracting mouse ascites when being slow in action, the centrifugal 8min of 2000r/min, discard fat and collect upper strata clarification ascites, measure with indirect ELISA method every the mouse ascites collected and tire, will tire and be not less than 1:(1000 × 2 11) ascites mixing, mixed ascites is finally tired after measured as 1:(1000 × 2 12), hypotype is accredited as lgG2b;
Anti-enterorrhagia Bacillus coil 0157: the preparation of H7intimin protein monoclonal antibody monoclonal antibody sensitization latex reagent: 1. get the carboxylated polystyrene latex 200ul shaken up and put into 4mlEP pipe; 2. use pH9.6,0.1M carbonate buffer solution washes 3 times, 12000rpm, 15min, centrifugally abandons supernatant; 3. use pH4.5 again, the phosphate buffer of 0.01M washes 3 times, 12000rpm, 15min, centrifugal, abandons supernatant; 4. the EDC then adding 100mM is resuspended, and the NHS1000uL of 20mM is resuspended, mixing, and EDC and NHS makes both final concentrations reach 50mol/L and 10mol/L respectively, and in shaking table, 26 DEG C slowly jolt 4.5h; 5. coupling terminate after sensitization latex pH8.0,0.01M borate buffer solution washes 3 times, 12000rpin, 20min, centrifugally abandons supernatant; 6. use pH8.0,0.01M borate buffer solution suspends, and suspension latex concentration is 2%, 4 DEG C and saves backup; 7. the anti-enterorrhagia Bacillus coil 0157 that 1:4 doubly dilutes dropwise slowly is added: H7intimin protein monoclonal antibody 1000ul, the protein content 2.78mg/mL of described protein monoclonal antibody, it is 1 hour that loading time controls, in 26 DEG C of shaking tables, slowly jolt 5h; 8. add terminator 0.1M monoethanolamine and in 26 DEG C of shaking tables, slowly jolt 15min cessation reaction (being add 50uL ethanolamine solutions in the 1mL antibody latex of 1% by concentration), 12000rpm, 20min; 9. use 5. same method process sensitization carboxylated latex, resuspended, 4 DEG C save backup.
Anti-enterorrhagia Bacillus coil 0157: concrete preparation method's condition of H7intimin protein monoclonal antibody sensitization latex reagent is groped as follows:
1, the preparation of 2% carboxylated latex: 1. get the carboxylated latex that 200uL shakes up and put into 4mlEP pipe; 2. use pH9.6,0.1M carbonate buffer solution washes 3 times, 12000rpm, 15min, centrifugally abandons supernatant; 3. use pH4.5 again, the phosphate buffer of 0.01M washes 3 times, 12000rpm, 15min, centrifugal, abandons supernatant; 4. the EDC1000uL then adding 100mM is resuspended, the NHS1000uL mixing of 20mM, and EDC and NHS makes both final concentrations reach 50mol/L and 10mol/L respectively, and in shaking table, 26 DEG C slowly jolt 4.5h; 5. coupling terminate after sensitization latex pH8.0,0.01M borate buffer solution washes 3 times, 12000rpin, 20min, centrifugally abandons supernatant; 6. use pH8.0,0.01M borate buffer solution 1000ul suspends, and suspension latex concentration is 2%, 4 DEG C and saves backup.
2, the selection of optimum monoclonal antibody addition during sensitization: get above-mentioned 2% carboxylated latex prepared of 100uL, add the dilution monoclonal antibody of difference (doubling dilution 1:1,1:2,1:4,1:8,1:16) of 100uLBBS dilution, slowly 5h is jolted in 26 DEG C of shaking tables, add 10uL0.1M monoethanolamine terminator 15min cessation reaction in 26 DEG C of shaking tables, 12000rpm, 20min, get supernatant to measure, precipitation pH8.0,0.01M borate buffer solution washes 3 times, then use 200ul pH8.0,0.01M borate buffer solution is resuspended.With the sensitization latex prepared, the dilution positive control sample of difference is detected, carry out the detection from coagulation phenomena simultaneously.The supernatant reclaimed measures protein content through UV-120 ultraviolet spectrophotometer.Adding protein content before sensitization is X1mg/mL, and after sensitization, supernatant protein content is X2mg/mL, calculates the protein content X=Xl-X2 (test findings is as table 1, table 2) of coupling.Test findings shows: during monoclonal antibody dilution 1:4 times, Conjugate ratio is the highest, and susceptibility is the highest, and the latex not self-solidifying after sensitization.
Form 1 adds the relation of protein content and coupling protein amount
Form 2 adds protein content and sensitivity relationship
3, the selection of best sensitization time: get the above-mentioned 2% carboxylated latex liquid prepared of 400ul, add the monoclonal antibody that 400ul 1:4 doubly dilutes, sensitization 1h, 2h, 3h, 4h, 5h, 6h and 7h respectively, 100ul is got in 1.5mlEP pipe every 1 hour, add 5uL0.1M monoethanolamine terminator cessation reaction, measure protein content before and after sensitization, calculate coupling protein amount and Conjugate ratio (test findings is as table 3, table 4).As seen from table, when coupling time is 5h, Conjugate ratio is the highest, and susceptibility is the highest, and the latex not self-solidifying after sensitization.
The relation of form 3 coupling time and Conjugate ratio
The relation of form 4 coupling time and susceptibility
4, different sensitization paradigm is on the impact of Conjugate ratio
Adopt best sensitization temperature, best sensitization time, best sensitizing antibody amount, study the impact of different sensitization paradigm on Conjugate ratio, what selection coupling efficiency was the highest is best sensitization paradigm (test findings is as table 5).It is the highest that result shows to adopt " the slow jolting of shaking table, monoclonal antibody dropwise slowly add, control whole loading time is 1 hour " this mode Conjugate ratio.
The different sensitization paradigm of form 5 is on the impact of Conjugate ratio
5, self-solidifying inspection: replace measuring samples to detect with the PBS, sterile saline, sterile purified water etc. of equivalent, observe the self-solidifying (test findings is as table 6) of sensitization latex.The results are shown in lower form:
Table 6 self-solidifying is tested
Indicate: ++++be 100% latex agglutination, latex forms large particle aggregation in drop edge, and liquid presents completely transparent state (as Figure 1A); +++ be the latex agglutination of 75%, have obvious particle to be formed, liquid slightly muddy (as Figure 1B); ++ be the latex agglutination of 50%, have obviously but the formation of thinner particle, flowing fluid ratio more muddy (as Fig. 1 C); + there is a little aggegation, liquid is muddy state (as Fig. 1 D);-not aggegation, drop presents original even emulsus (as Fig. 1 E).Result is to occur ++ above latex agglutination is positive.
Embodiment 2 enterorrhagia Bacillus coil 0157: the using method of H7 latex agglutination assay kit
1, the process of sample: the measuring samples collected is placed in sample treatment liquid 37 DEG C and cultivates 4-6 hour.
2, the detection of test sample: 1) drip 10ul positive control sample, 10ul negative control sample and 10ul measuring samples respectively on clean slide or glass plate.And then heliotropism control sample, negative control sample, the latex dripped in measuring samples described in 10ul detect reagent, stir, to shake after 1 minute observations under blue background.2) result judges: control test occurred following result in 1 minute, and test can be set up: positive control sample and latex detect reagent effect and occur +++ above latex agglutination, and negative control sample and latex detect reagent not aggegation; Measuring samples occurred in 1 minute ++ above latex agglutination is judged to the positive, presents original even emulsus and is judged to be feminine gender.
Kit can directly to the enterorrhagia Bacillus coil 0157 in sample: H7 detects, if containing enterorrhagia Bacillus coil 0157: H7 in sample, then latex detects reagent and occurred in 1 minute ++ and above latex agglutination, can be judged to positive findings; If not containing enterorrhagia Bacillus coil 0157: H7 in sample, then latex detection reagent drop in 1 minute still presents original even emulsus, can be judged to negative findings.
Embodiment 3 enterorrhagia Bacillus coil 0157: the Preliminary Applications of H7 latex agglutination assay kit
1, sensitivity tests: the enterohemorrhagic Escherichia coli list bacterium colony on picking sorbierite Mai Kangkai plate after 37 DEG C of cultivation 18-24h, 18-24h is cultivated in 5mLTSB fluid nutrient medium, with colony counting method, bacterium is counted, and bacterium liquid is carried out different gradient dilution, with spectrophotometer bacterial detection bacterium liquid OD 600value, then carries out detecting (test findings is as table 7) with the latex reagent that sensitization is good.Test findings: bacterium liquid is diluted to 1:256 doubly (bacterium amount 2.3 × 10 7cFU/ml), time, still can occur obvious visible agglutinating reaction, test findings shows that susceptibility is better.
Form 7 sensitivity tests
2, specific test: latex reagent good for sensitization is carried out latex agglutination detection with cause of diseases such as salmonella, other serotypes of Escherichia coli, avian pasteurella multocida, ewcastle diseases respectively, its specificity is studied (test findings is as table 8).Test findings: sensitization latex reagent and Escherichia coli O 157: H7 reacts for positive, and react with the cause of disease such as avian pasteurella multocida, salmonella and be feminine gender, test findings shows that specificity is better.
Form 8 specific test
Antigen State of aggregation Antigen State of aggregation
Avian pasteurella multocida - Escherichia coli O78 -
Salmonella - Escherichia coli O1 -
Positive control ++++ Negative control -
Escherichia coli O 157: H7 ++++ Ewcastle disease -
3, replica test
3.1, interior replica test is criticized: prepare 3 batches of enterorrhagia Bacillus coil 0157s: H7 latex agglutination antigen detection kit (kit lot number is respectively 1401,1402,1403), 10 every batch, in every batch of kit, randomly draw 3 kits detect positive control sample, negative control sample, enterorrhagia Bacillus coil 0157: H7 and salmonella, avian pasteurella multocida, observe its susceptibility, specificity and stability, and detect latex whether self-solidifying (test findings is as table 9).Result shows that its susceptibility, specificity and stability do not change, and illustrates that batch interior repeatability is good.
Replica test in form 9 batches
3.2, criticize between replica test: be chosen at 3 batches of enterorrhagia Bacillus coil 0157s prepared by different time: H7 latex agglutination antigen detection kit (kit lot number is respectively 1401,1402,1403), detect with a positive control sample, negative control sample, enterorrhagia Bacillus coil 0157: H7 and salmonella, avian pasteurella multocida, observe its susceptibility, specificity and stability, and detect latex whether self-solidifying (test findings is as table 10).Result shows that its susceptibility, specificity and stability do not change, and illustrates that between criticizing, repeatability is good.
Replica test between form 10 batches
4, coincidence rate test: the contaminated samples of manual simulation is detected.Select the ddH of 50 parts of sterilizings 2o, therefrom Stochastic choice 30 parts manually adds enterorrhagia Bacillus coil 0157: H7, adopts the latex agglutination antigen detection kit of the present invention's assembling and PCR method to detect (test findings is as table 11) 50 above-mentioned increment product respectively.The latex agglutination antigen detection kit that result shows the present invention's assembling detects positive 29 parts, and positive rate is 96.67%; Detect negative sample 21 parts, negative recall rate is 100%; Compare with PCR testing result, total coincidence rate is 98.00%.
Form 11 coincidence rate test findings
Embodiment 4 enterorrhagia Bacillus coil 0157: the assembling of H7 latex agglutination assay kit
1, enterorrhagia Bacillus coil 0157: H7 latex agglutination antigen detection kit, comprises
2, the preparation of related solution
1) preparation of sample treatment liquid: take tryptone 20.0g, No. 3 cholate 1.12g, lactose 5.0g, ADKP 4.0g, anhydrous potassium dihydrogenphosphate 1.5g, NaCl 5.0g, ddH 2water-soluble for mentioned component rear adjust pH is 6.9 ± 1,121 DEG C of autoclaving 15min by O1000ml, and take out the ovobiocin solution 20mg/L filtering sterilizing and add, make ultimate density be 20ug/L, packing after mixing, 4 DEG C save backup.
2) preparation of positive control sample: by enterorrhagia Bacillus coil 0157: H7 bacterial strain is 37 DEG C of cultivation 18-24 hour in autoclaved TSB, adding formalin makes its final concentration be 0.2%, 37 DEG C of slow jolting 72h in shaking table, be dispensed in 1.5mlEP pipe ,-20 DEG C save backup.
3) preparation of negative control sample: not containing enterorrhagia Bacillus coil 0157: the autoclaved TSB nutrient solution of H7 bacterial strain, be dispensed in 1.5mlEP pipe ,-20 DEG C save backup.

Claims (6)

1. an enterorrhagia Bacillus coil 0157: H7 latex agglutination assay kit, it is characterized in that this kit comprises: a) latex detects reagent, b) sample treatment liquid, c) positive control sample, d) negative control sample, it is energy and enterorrhagia Bacillus coil 0157 that described latex detects reagent: the latex reagent of H7 specific reaction, adopts anti-Intimin protein monoclonal antibody sensitization carboxylated polystyrene latex gained.
2. by enterorrhagia Bacillus coil 0157 according to claim 1: H7 latex agglutination assay kit, it is characterized in that the preparation method of described anti-Intimin protein monoclonal antibody is: screen from 5 strain of hybridoma building strain 1 strain antibody tire height, high specificity hybridoma expand and cultivate, simultaneously in BALB/c mouse body, induce mouse ascites manufacture order clonal antibody; Get the BALB/c mouse 20 in 8 week age, only, the injection of 7d pneumoretroperitoneum expands the hybridoma 5 × 10 cultivated to the incomplete freund adjuvant 0.5mL/ of lumbar injection 6~ 5 × 10 7/ only, breeding observing, until mouse web portion projection and by only extracting mouse ascites when being slow in action, the centrifugal 8min of 2000r/min, discard fat and collect upper strata clarification ascites, measure with indirect ELISA method every the mouse ascites collected and tire, will tire and be not less than 1:(1000 × 2 11) ascites mixing, mixed ascites is finally tired after measured as 1:(1000 × 2 12), hypotype is accredited as lgG2b.
3. by enterorrhagia Bacillus coil 0157 according to claim 1: H7 latex agglutination assay kit, is characterized in that the concrete preparation method of described anti-Intimin protein monoclonal antibody sensitization carboxylated polystyrene latex: (1) is got the carboxylated polystyrene latex 200ul shaken up and put into EP pipe; (2) wash 3 times, 12000rpm, 15min with pH9.6,0.1M carbonate buffer solution, centrifugally abandon supernatant; (3) use pH4.5 again, the phosphate buffer of 0.01M washes 3 times, 12000rpm, 15min, centrifugal, abandons supernatant; (4) the NHS 1000uL then adding EDC 1000uL, 20mM of 100mM is resuspended, mixing, and make both final concentrations be respectively 50mol/L and 10mol/L, in shaking table, 26 DEG C slowly jolt 4.5h; (5) wash 3 times, 12000rpin, 20min with pH8.0,0.01M borate buffer solution, centrifugally abandon supernatant; (6) suspend with pH8.0,0.01M borate buffer solution 1000ul, suspension latex concentration is 2%, 4 DEG C and saves backup; (7) the anti-enterorrhagia Bacillus coil 0157 that 1:4 doubly dilutes dropwise slowly is added: H7intimin protein monoclonal antibody 1000ul, the protein content 2.78mg/mL of described protein monoclonal antibody, it is 1 hour that loading time controls, in 26 DEG C of shaking tables, slowly jolt 5h; (8) add 0.1M monoethanolamine 100ul, in 26 DEG C of shaking tables, slowly jolt 15min cessation reaction, 12000rpm, 20min, centrifugally abandon supernatant; (9) precipitation pH8.0,0.01M borate buffer solution washes 3 times, 12000rpin, 20min, centrifugally abandons supernatant; (10) precipitation pH8.0,0.01M borate buffer solution 2000ul suspends, and is the good latex of sensitization and detects reagent, 4 DEG C of preservations.
4. by enterorrhagia Bacillus coil 0157 according to claim 1: H7 latex agglutination assay kit, it is characterized in that the component of described sample treatment liquid and content by weight/volume is: take tryptone 20.0g, No. 3 cholate 1.12g, lactose 5.0g, ADKP 4.0g, anhydrous potassium dihydrogenphosphate 1.5g, NaCl 5.0g, is dissolved in 1000ml ddH by mentioned component 2o, adjust pH is 6.9 ± 1,121 DEG C of autoclaving 15min, and the ovobiocin solution 20mg/L taking out filtration sterilization adds, and makes ultimate density be 20ug/L.
5. by enterorrhagia Bacillus coil 0157 according to claim 1: H7 latex agglutination assay kit, it is characterized in that described positive control sample is the enterorrhagia Bacillus coil 0157 of deactivation: H7 bacteria suspension, described negative control sample is not containing the autoclaved TSB nutrient solution of Escherichia coli O 157: H7.
6. enterorrhagia Bacillus coil 0157 according to claim 1: the application of H7 latex agglutination assay kit, is characterized in that comprising following concrete steps: the measuring samples 37 DEG C of cultivation 4-6 hour in sample treatment liquid 1) will collected; 2) on clean slide or glass plate, 10ul positive control sample, 10ul negative control sample and 10ul measuring samples is dripped respectively, and then heliotropism control sample, negative control sample, the latex dripped in measuring samples described in 10ul detect reagent, abundant mixing, slow shake, after 1 minute under blue background observations; 3) result judges: control test occurs following result in 1 minute, and test can be set up: positive control sample and latex detect reagent effect and occur +++ above latex agglutination, and negative control sample and latex detect reagent effect not aggegation; Measuring samples occurred in 1 minute ++ above latex agglutination is judged to the positive, presents original even emulsus and is judged to be feminine gender.
CN201510189310.7A 2015-04-21 2015-04-21 A kind of enterorrhagia Bacillus coil 0157: H7 latex agglutination assay kit and application Active CN104849470B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510189310.7A CN104849470B (en) 2015-04-21 2015-04-21 A kind of enterorrhagia Bacillus coil 0157: H7 latex agglutination assay kit and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510189310.7A CN104849470B (en) 2015-04-21 2015-04-21 A kind of enterorrhagia Bacillus coil 0157: H7 latex agglutination assay kit and application

Publications (2)

Publication Number Publication Date
CN104849470A true CN104849470A (en) 2015-08-19
CN104849470B CN104849470B (en) 2016-08-24

Family

ID=53849267

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510189310.7A Active CN104849470B (en) 2015-04-21 2015-04-21 A kind of enterorrhagia Bacillus coil 0157: H7 latex agglutination assay kit and application

Country Status (1)

Country Link
CN (1) CN104849470B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106706904A (en) * 2016-11-25 2017-05-24 湖北省农业科学院畜牧兽医研究所 Pullorum disease antibody latex agglutination negative selection detection kit as well as preparation method and application thereof
CN108254559A (en) * 2018-01-03 2018-07-06 北京市理化分析测试中心 The method of quick detection microorganism

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6057255A (en) * 1983-09-09 1985-04-03 Green Cross Corp:The Aqueous solvent for testing agglutination
CN1978634A (en) * 2005-12-02 2007-06-13 华中农业大学 Avianinflu virus H5 subtype emulsion agglutination kit and its use
CN104407145A (en) * 2014-10-28 2015-03-11 绍兴市疾病预防控制中心 Enterovirus 71 type latex agglutination detection kit, preparation and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6057255A (en) * 1983-09-09 1985-04-03 Green Cross Corp:The Aqueous solvent for testing agglutination
CN1978634A (en) * 2005-12-02 2007-06-13 华中农业大学 Avianinflu virus H5 subtype emulsion agglutination kit and its use
CN104407145A (en) * 2014-10-28 2015-03-11 绍兴市疾病预防控制中心 Enterovirus 71 type latex agglutination detection kit, preparation and application

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAJRA,TK.ET.AL: "Development of a simple latex agglutination assay for detection of Shiga Escherichia coli (STEC)by using polyclonal antibody against STEC", 《CLINICAL AND VACCINE IMMUNOLOGY》 *
罗玲等: "肠出血性大肠杆菌O157:H7 intimin蛋白单克隆抗体的制备与鉴定", 《中国家禽》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106706904A (en) * 2016-11-25 2017-05-24 湖北省农业科学院畜牧兽医研究所 Pullorum disease antibody latex agglutination negative selection detection kit as well as preparation method and application thereof
CN106706904B (en) * 2016-11-25 2018-06-29 湖北省农业科学院畜牧兽医研究所 White diarrhea antibody latex agglutination bears selective mechanisms kit and preparation method and application
CN108254559A (en) * 2018-01-03 2018-07-06 北京市理化分析测试中心 The method of quick detection microorganism

Also Published As

Publication number Publication date
CN104849470B (en) 2016-08-24

Similar Documents

Publication Publication Date Title
CN103123354B (en) Immunodetection assay for mycobacterium tuberculosis complex
Wuthiekanun et al. a rapid method for the differentiation of Burkholderia pseudomallei and Burkholderia thailandensis.
CN104628833B (en) A kind of tuberculosis infection cellular immunization detectable antigens composition and application thereof
CN101014622B (en) Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same
CN105067812A (en) Bovine brucella indirect ELISA antibody detection kit
CN103941020B (en) A kind of indirect ELISA reagent kit detecting haemophilus parasuis antibody
CN106771182A (en) Brucella abortus IgM subclass antibodies indirect ELISA testing kits
CN101799470A (en) Brucellosis indirect enzyme-linked immunosorbent assay antibody detection kit
CN106596958B (en) Brucellosis CF-ELISA antibody assay kits
CN104849470A (en) Enterohemorrhagic E.coli O157:H7 latex agglutination detection kit and application thereof
CN101699292A (en) Rabbit monoclonal antibody based ciprofloxacin residue analysis enzyme-linked immune adsorption kit
CN109239341B (en) Indirect ELISA kit for detecting bovine haemolytic mannheimia antibody and application thereof
CN104198737B (en) Based on the bioprobe of staphylococcus aureus, preparation method and application thereof
CN102033128B (en) Edwardsiella tarda rapid detection test paper as well as rapid detection method and application
CN105866437B (en) A kind of VREF indirect hemagglutination detection kit and its application
CN105759054B (en) A kind of ELISPOT detection kits for being used to detect B.abortus disease
CN104628834B (en) A kind of tuberculosis infection T cell immunodetection antigen and application thereof
JP5467228B2 (en) Rapid detection method of Campylobacter in stool
CN107907680B (en) Colloidal gold immune test paper for detecting bacillus larvae of bees and preparation and application thereof
KR101917823B1 (en) Composition and method for detecting Shigella spp. belonging to 4 serotype groups
CN105585634B (en) The immune chromatography reagent kit of anti-human streptococcus pneumonia fam2 family PspA protein antibodies and the application antibody
CN105315367A (en) Enzyme-linked immunoassay kit for detecting methicillin-resistant staphylococcus aureus
CN117447602B (en) Antibodies to porcine IgM and uses thereof
CN117447601B (en) Antibodies to porcine IgM, antibody compositions and uses thereof
CN1982439A (en) Reagent kit for inspecting bovine antibody and its use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20221107

Address after: 528000 1st and 2nd floor, no.26-4, Zone C, Southwest Park, Sanshui Industrial Park, Foshan City, Guangdong Province

Patentee after: Guangdong zhengdakang Biotechnology Co.,Ltd.

Address before: No. 1, Nanhu Yao yuan, Hongshan District, Wuhan, Hubei

Patentee before: INSTITUTE OF ANIMAL SCIENCE AND VETERINARY, HUBEI ACADEMY OF AGRICULTURAL SCIENCES

TR01 Transfer of patent right